Harm Reduction for Tobacco Smoking With Support of Tobacco-Replacing Electronic Nicotine Delivery Systems
HaRTS-TRENDS
Randomized Controlled Trial of Harm Reduction for Tobacco Smoking With Support of Tobacco-Replacing Electronic Nicotine Delivery Systems (HaRTS-TRENDS)
1 other identifier
interventional
94
1 country
1
Brief Summary
This study will evaluate the effectiveness of HaRTS-TRENDS compared to standard care (i.e., brief advice to quit + referral to state quit line that offers free NRT) in facilitating a biochemically verified nonsmoking and b) reducing smoking-related harm as measured by concentration of urinary tobacco-specific nitrosamines (TSNAs). Potential underlying mechanisms of changes in the proposed outcomes--including nicotine craving and smoking reduction, respectively--will be tested.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 9, 2019
CompletedFirst Submitted
Initial submission to the registry
May 17, 2019
CompletedFirst Posted
Study publicly available on registry
May 24, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedMay 24, 2019
May 1, 2019
2 years
May 17, 2019
May 22, 2019
Conditions
Outcome Measures
Primary Outcomes (2)
Nonsmoking
Biologically verified nonsmoking (i.e., self-reported nonsmoking if corresponding CO measure is \< 8) in the past 7 days will serve as a primary outcome as well as a potential mediator of the HaRTS-TRENDS effect on TSNA concentration.
Change across the 12-month follow-up
TSNA Concentration
This primary outcome entails urinary concentration of a tobacco-specific nitrosamine (i.e., NNK), a key carcinogen in tobacco. Secondarily, TSNA concentration will be used as a longer-term biochemical index of tobacco use.
Change across the 12-month follow-up
Secondary Outcomes (7)
smoking intensity
Change across the 12-month follow-up
smoking frequency
Change across the 12-month follow-up
CO level
Change across the 12-month follow-up
cotinine levels
Change across the 12-month follow-up
FEV1%
Change across the 12-month follow-up
- +2 more secondary outcomes
Other Outcomes (2)
smoking craving
Change across the 12-month follow-up
side effects of ENDS
Change across the 12-month follow-up
Study Arms (2)
HaRTS-TRENDS
EXPERIMENTALSee description below.
Standard Care (SC)
ACTIVE COMPARATORSee description below.
Interventions
HaRTS-TRENDS comprises 4, individual sessions delivered in the context of the interventionist's pragmatic harm-reduction mindset paired with a compassionate, advocacy-oriented "heart-set" or style. It comprises the delivery of 4 manualized components, including a) participant-led tracking of preferred smoking outcomes, b) elicitation of participants' harm-reduction goals and their progress toward achieving them, c) discussion of the relative risks of various nicotine delivery systems, and d) instruction in using ENDS. Additionally, HaRTS-TRENDS entails provision of commercially available ENDS.
The 4-session, individual standard care control condition entails the well-documented and evidence-based 5 As intervention (i.e., Ask about nicotine use, Assess use, Advise to quit smoking, Assist with exploring current smoking/planning smoking cessation, Arrange follow-up). Part of arranging follow-up is the recommendation to call the smoking quit line, which can supply additional counseling and nicotine replacement therapy.
Eligibility Criteria
You may qualify if:
- Having a history of chronic homelessness according to the widely accepted federal definition,
- Being a current DESC client living in one of DESC's participating permanent supportive housing projects,
- Being between 21-65 years of age,
- Being a daily smoker (\>4 cigarettes/day in the past year with a breath CO ≥ 6 ppm or salivary cotinine test at level 1 if CO \< 6 ppm)
- Having adequate English language skills to understand verbal information and communicate in the study
You may not qualify if:
- Use of other tobacco products besides cigarettes ≥ 9 days in the past month
- Refusal or inability to consent to participation in research
- Constituting a risk to the safety and security of other clients or staff.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Washingtonlead
- Downtown Emergency Service Centercollaborator
- Washington State Universitycollaborator
Study Sites (1)
University of Washington - Harborview Medical Center
Seattle, Washington, 98195, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Susan E Collins, PhD
University of Washington
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, School of Medicine: Psychiatry
Study Record Dates
First Submitted
May 17, 2019
First Posted
May 24, 2019
Study Start
May 9, 2019
Primary Completion
April 30, 2021
Study Completion
December 31, 2021
Last Updated
May 24, 2019
Record last verified: 2019-05
Data Sharing
- IPD Sharing
- Will not share
The proposed research will involve people recruited from prominent Housing First programs serving chronically homeless people who are often multiply affected by psychiatric, medical and substance-use disorders. The proposed sample will be recruited from a highly vulnerable and marginalized population in a tight-knit urban community. Furthermore, the partnering agency is well-known for its housing approach, and regularly conducts tours to help inform other housing providers, policy makers, and other public stakeholders about this model to promote replicability. Thus, even with the removal of all identifiers, we believe that it could become difficult to fully protect the identities of participants and their data (including e-cigarette use and smoking which are not currently allowed in housing). For these reasons, we do not have immediate plans to share the data collected in the context of the proposed study.